Trattamento ormonale sostitutivo in menopausa: Benefici terapeutici e rischi preventivi

Translated title of the contribution: Hormonal replacement therapy: Therapeutical benefits and preventive risks

Franco Berrino

Research output: Contribution to journalArticlepeer-review

Abstract

Hormonal replacement therapy is prescribed both to relieve menopausal symptoms and for preventive purposes. The preventive benefit, however, is dubious because the increased risk of breast cancer may be more important than the decreased risk of myocardial infarction and osteoporotic fractures. The transdermal administration may be associated with higher breast cancer risk and lower cardiovascular benefit than the oral administration; only the latter, in fact, is able to stimulate the liver synthesis of sex hormone binding globulin (SHBG, which reduces the availability of testosterone and estradiol to target organs) and of HDL cholesterol, and to inhibit the liver synthesis of IGF-I (which cooperates with sex steroids to enhance the breast cancer cell proliferation).

Translated title of the contributionHormonal replacement therapy: Therapeutical benefits and preventive risks
Original languageItalian
Pages (from-to)213-215
Number of pages3
JournalAnnali dell'Istituto Superiore di Sanita
Volume33
Issue number2
Publication statusPublished - 1997

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Fingerprint Dive into the research topics of 'Hormonal replacement therapy: Therapeutical benefits and preventive risks'. Together they form a unique fingerprint.

Cite this